Targeting the Kinome

The meeting is partially prompted by the fact that 2006 will see the 20th anniversary of the start of tyrosine kinase inhibitor research in Basel. This event ultimately led to the development of the first protein kinase therapeutic, Glivec. The symposium will focus on the impact of basic research on drug discovery and the impact that it is now having on treatment of cancer. We also wish to focus on contemporary issues in the protein kinase field, surveying the current landscape in terms of the development of targeted kinase inhibitors for cancer, and other areas. We hope to bring together basic researchers, chemists, pharmacologists, clinicians and the major contributors from the pharma industry.

We look forward very much to your participation.

Organizers:

• – Dr Brian A. Hemmings, FMI, Basel
• – Prof. Paul Herrling, Corporate Research, Novartis, Basel
• – Dr. Myoung-Ok Kwon, Corporate Research, Novartis, Basel

Scientific committee:

• – Prof. Max M. Burger, Novartis Science Board, Basel
• – Dr Brian A. Hemmings, FMI, Basel
• – Prof. Paul Herrling, Corporate Research, Novartis, Basel
• – Prof. Bill Sellers, NIBR, Boston

We would also like to talk about the scientific activities of our partners and about their useful functions, maybe you were wondering , who can do my assignment for me? If this is the only thought in your head right now, you need urgent help with your homework. No worries, you are not the only student in academic trouble. Do my assignment for me cheap — this is one of the most frequent requests by students on the internet. It only means that many of them struggle with their writing assignments.